Seattle / Baltimore City / Rockville / Baltimore / Berlin / Atlanta / Amsterdam / New York City / Chicago / /
Company
Hoover / non-HCV / Strathdee SA. / HCV / Pearson / Villano SA / /
Country
France / United States / /
Currency
USD / / /
Event
M&A / /
Facility
National Institute / /
IndustryTerm
Hepatitis C Prevention / drug preparation equipment / HCV therapy / injection equipment / HIV prevention / nonHCV / HCV prevention / peer networks / treatment for hepatitis C / social network / /
MedicalCondition
J Drug Alcohol Abuse / prevalence hepatitis C / HIV / HCVassociated liver cirrhosis / HBV / positive hepatitis C / hepatitis C / hepatitis B / HIV epidemic / virus infections / liver cirrhosis / end-stage liver disease / infections / Mental Disorders / HIV infection / disease / hepatocellular carcinoma / progressive liver disease / bloodborne infections / Viral infections / Clinical Infectious Diseases / Virus Infection / HCVrelated chronic disease / Drug Abuse / infection / human immunodeficiency virus infection / HCV disease / /
MedicalTreatment
counseling / /
Organization
Johns Hopkins School of Medicine / US Department of Health and Human Services / Johns Hopkins University School of Hygiene and Public Health / Johns Hopkins University Bloomberg School of Public Health / and 2Department of Medicine / Department of Epidemiology / National Institute on Drug Abuse / Public Health Service / Infectious Diseases Society of America / Centers for Disease Control and Prevention / Department of Medicine / New York Academy of Medicine / Johns Hopkins University Bloomberg School of Public Health / Johns Hopkins School of Public Health / Mailman School of Public Health / office of Applied Studies / Substance Abuse and Mental Health Services Administration / Medicine / and 4Columbia University / /
Person
Van den Hoek / Karen Nolt / Van Ameijden / Van Haastrecht / Danielle C. Ompad / Ellen Taylor / Vidal-Tre / Steffanie A. Strathdee / / /
Position
physician / counselor / Calculated using Fisher / Major / /
Product
HIV / x2 / Young Injection / calculated using Pearson’s x2 / /
MAJOR ARTICLE Lack of Behavior Change after Disclosure of Hepatitis C Virus Infection among Young Injection Drug Users in Baltimore, Maryland Danielle C. Ompad,1,3 Crystal M. Fuller,3,4 David Vlahov,1,3,4 David Thomas,2